Centralised authorisation procedure 2012
The Danish share of assignments in the European pharmaceutical collaboration
The Danish Health and Medicines Authority should have the greatest possible influence on decisions regarding new medicinal products and thereby the greatest possible influence on the future development of the European market for medicinal products.
Status for 2012 up to and including 4th quarter:
Denmark was assigned 6 human rapporteur/co-rapporteur cases and 6 veterinary rapporteur/co-rapporteur cases, which is respectively 3 % and 8 % of all assigned central procedure cases in 2012.
Figure 1: Amount of assigned (co)rapporteurships in the EU in 2012 up to and including 4th quarter
Figure 2. Share of human Rap/Co-rap cases
View table 1 – Assigned human rapporteur/co-rapporteur cases
Figure 3. Share of veterinary Rap/Co-rap cases
View table 2 - Assigned veterinary rapporteur/co-rapporteur cases